About this episode
In late 2025 and early 2026, the FDA removed the “black box” warning label found on certain menopausal hormone therapy products, including estrogen patches. The removal of this warning paired with a surge in demand for medications for perimenopause and menopause has resulted in a shortage of estrogen patches, leaving many patients scrambling. Dr. Nesreen Hermes, a family medicine doctor in Illinois who regularly sees patients for perimenopause and menopausal symptoms, joined ForbesWomen editor Maggie McGrath to discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time Forbes Talks publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Forbes Talks
White House Refuses Elon Musk’s Offer To Pay TSA Staff Amid Partial Government S...
Forbes Talks
Mar 27, 20263:06completed
Meta And Google Found Liable In Social Media Addiction Trial
Forbes Talks
Mar 27, 20262:58completed
Wall Street Bonuses Surged To A Record $49.2 Billion Pool Last Year
Forbes Talks
Mar 27, 20263:41completed
Why AI Is Increasing Workplace Complexity Instead Of Reducing Employee Workloads
Forbes Talks
Mar 26, 202620:36failed